Capricor Therapeutics, Inc. , a diversified heart failure biotechnology company, today announced that, effective today, the Company's common stock commences trading on the OTC Markets under the new symbol "CAPR."
http://www.businesswire.com/news/topix/20131220005186/en
http://www.businesswire.com/news/topix/20131220005186/en
No comments:
Post a Comment